Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

Ewa Orlewska,I. Ancuta,Branimir Anic,Catalin Codrenau,Nemanja Damjanov,Predrag Djukic,R. Ionescu,Lubomir Marinchev,Nasonov El,Tõnu Peets,S. Praprotnik,Rasho Rashkov,Jana Skoupá,Witold Tłustochowicz,Małgorzata Tłustochowicz,Matija Tomšič,Tiina Veldi,Jelena Vojinovic,Piotr Wiland

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

2011

Ewa Orlewska
I. Ancuta
Branimir Anic
Catalin Codrenau
Nemanja Damjanov
Predrag Djukic
R. Ionescu
Lubomir Marinchev
Nasonov El
Tõnu Peets
S. Praprotnik
Rasho Rashkov
Jana Skoupá
Witold Tłustochowicz
Małgorzata Tłustochowicz
Matija Tomšič
Tiina Veldi
Jelena Vojinovic
Piotr Wiland

Background The aim of this study was to assess and compare patients’ access to biologic anti-RA drugs in selected Central and Eastern European (CEE) countries and to analyze the determinants of differences between countries.

Keywords:

Alternative medicine
Rheumatoid arthritis
Arthritis
Diabetes mellitus
Antirheumatic Agents
Medicine
Physical therapy
biologic treatment
Endocrinology
eastern european
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations